Singapore markets close in 25 minutes
Straits Times Index
3,287.76 -4.93 (-0.15%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,207.13 +444.10 (+2.50%) FTSE 100
8,160.67 +39.43 (+0.49%) Bitcoin USD
57,852.60 +925.31 (+1.63%) CMC Crypto 200
1,264.63 -6.11 (-0.48%)
Sarepta Therapeutics, Inc. (SRPT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 126.66 |
| Open | 127.06 |
| Bid | 130.60 x 100 |
| Ask | 131.23 x 100 |
| Day's range | 127.00 - 131.61 |
| 52-week range | 55.25 - 159.89 |
| Volume | |
| Avg. volume | 854,572 |
| Market cap | 12.371B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Sarepta Therapeutics Inc (SRPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...
Discover key insights from Sarepta Therapeutics' Q1 2024 earnings, including significant revenue increases and promising developments in drug approvals and market expansions.
- Zacks
Sarepta Therapeutics (SRPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Sarepta Therapeutics (SRPT) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- Zacks
Sarepta Therapeutics (SRPT) Q1 Earnings and Revenues Beat Estimates
Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of 763.64% and 10.91%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.